DRL re-launches Buprenorphine and Naloxone Sublingual Film in US
The re-launch comes on the heels of a favourable decision issued by the United States Court of Appeals for the Federal Circuit
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
US top court denies Indivior’s request on suboxone
Indivior is in legal battle against the launch of copycat version of its opioid addiction treatment by competitors including Dr…
Strides Pharma Science arm gets USFDA nod for anti-epileptic drug
The approved product is a generic version of Zarontin Capsules, 250 mg, of Pfizer
ACG commits to further investment in Brazil
ACG Capsules launches a new factory in Pouso Alegre-MG, generating local employment
Alembic Pharma gets USFDA nod for ophthalmic solution
With this, the company now has a total of 86 ANDA approvals from the USFDA
Government’s intervention in oxytocin production unwarranted, says IMA
Oxytocin is provided to pregnant women during and post child birth to control bleeding
Cipla and Wellthy Therapeutics partner to offer digital therapeutics for diabetes and cardiovascular…
Under the agreement, a multi-lingual clinically-validated digital disease management platform will be made available to patients…
GSK Consumer Healthcare posts Rs 1117-crore revenue in Q3
Revenue growth at 7.5 per cent, PBT growth at 37 per cent
Sadananda Gowda seeks active participation of pharma sector in Ayushman Bharat
The summit provided an ideal platform to deliberate upon strategies to help the country innovate and bring newer, affordable and…
Taking a stand for trust
Mohan Joshi, Independent Management Consultant
You land in a new place and spend a couple of nights at a stranger’s house. You…